Free Trial

Neurogene (NGNE) Earnings Date, Estimates & Call Transcripts

Neurogene logo
$15.33 -0.81 (-5.02%)
Closing price 04:00 PM Eastern
Extended Trading
$15.06 -0.27 (-1.73%)
As of 05:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neurogene Latest Earnings Summary

Upcoming Q1
Earnings Date
May. 9Before Market OpensEstimated
Actual EPS
(Mar. 24)
-$0.99 Beat By $0.05
Consensus EPS
(Mar. 24)
-$1.04

Neurogene announced Q4 2024 earnings on March 24, 2025, reporting an EPS of -$0.99, which beat analysts' consensus estimates of -$1.04 by $0.05. Quarterly revenue was reported to be $0.93 million. With a trailing EPS of -$4.27, Neurogene's earnings are expected to grow next year, from ($4.27) to ($4.08) per share.

NGNE Upcoming Earnings

Neurogene's next earnings date is estimated for Friday, May 9, 2025, based off prior year's reporting schedules.

Get Neurogene Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Neurogene and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

NGNE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NGNE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

Neurogene Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20253-$1.12-$0.85-$0.96
Q2 20253-$1.18-$0.89-$0.99
Q3 20253-$1.19-$0.93-$1.02
Q4 20253-$1.27-$0.95-$1.07
FY 202512-$4.76-$3.62-$4.05
Q1 20261-$1.18-$1.18-$1.18
Q2 20261-$1.11-$1.11-$1.11
Q3 20261-$1.14-$1.14-$1.14
Q4 20261-$1.16-$1.16-$1.16
FY 20264($4.59)($4.59)($4.59)
Remove Ads

Neurogene Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/9/2025
(Estimated)
-------
3/24/2025Q4 2024-$1.04-$0.99+$0.05-$0.99-$0.93M
8/9/2024--$1.02-$1.09 -$0.07-$1.09-$0.93M
5/10/2024Q1 2024-$1.03-$1.00+$0.03-$1.00--
11/14/2023Q3 2023-$3.20-$1.64+$1.56-$1.64--
8/10/2023Q2 2023-$3.00-$0.80+$2.20-$0.80--
5/8/2023Q1 2023-$3.60-$4.00 -$0.40-$2.80--

Neurogene Earnings - Frequently Asked Questions

Neurogene has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 9th, 2025 based off last year's report dates. Learn more on NGNE's earnings history.

In the previous quarter, Neurogene (NASDAQ:NGNE) reported ($0.99) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.04) by $0.05. Learn more on analysts' earnings estimate vs. NGNE's actual earnings.

Neurogene (NASDAQ:NGNE) has a recorded annual revenue of $925,000.00.

Neurogene (NASDAQ:NGNE) has a recorded net income of -$36.32 million. NGNE has generated -$4.27 earnings per share over the last four quarters.

Neurogene's earnings are expected to grow from ($4.27) per share to ($4.08) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:NGNE) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners